Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Low and very-low-field 3D magnetic resonance spirometry for advanced regional exploration of respiratory diseases

Project description

Revolutionising lung function imaging

Respiratory diseases including COVID-19 pose a major health threat as they affect lung function. Current diagnostic tools lack sensitivity, involve radiation exposure, or are costly. Funded by the European Innovation Council, the V-LF-Spiro3D project aims to develop a low-cost protocol for assessing lung function using MRI techniques. In collaboration with various stakeholders, the project will generate high-performance MRI hardware and use deep learning methods for data processing. The newly developed lung imaging technology will be applied in the diagnosis of six respiratory diseases, offering significant advancement at point-of-care imaging and digital health in the EU.

Objective

Lung function is a central concern in the fight against covid-19. Beyond the pandemic heavy losses and long-term health implications, respiratory diseases represent a major threat for the World Health Organisation. It is one of the leading causes of death worldwide, associated to our way of living and impacting all of society. Current tools for diagnosing and monitoring pulmonary conditions are hindered by poor sensitivity (lung function tests), radiation exposure (computed tomography) or examination cost (magnetic resonance imaging, MRI). They all differently fail to fully assess lung structure and function
V|LF-Spiro3D aims at democratizing newly developed and breakthrough 3D MR spirometry with high performance, low-cost MRI techniques to provide a ten-minute morphofunctional MRI protocol to engage patients in a safer, easier and more comfortable way.
Based on recent works at Universities Paris-Saclay and Aberdeen, in collaboration with leading MR manufacturer Siemens, SME NMR Service, major French-Dutch hospitals and patient organisations, V|LF-Spiro3D brings together multidisciplinary experts in a patient-oriented approach for both adults and children
V|LF-Spiro3D will redesign current MRI architecture to perform 3D MR spirometry at low and very low field. High-performance MRI hardware will be developed with accelerated acquisitions and coupled reconstruction strategies relying on deep learning. Biomechanical lung modelling and deep data processing will be guided by implementation of 3D MR spirometry in clinical facilities to produce unprecedentedly large sets of normative and training data covering six major respiratory diseases
By prioritizing both technology transfer and innovation, V|LF-Spiro3D aims to build up a one-stop-shop imaging standard for unrestricted assessment of lung pathophysiology. The impacts are expected to yield benefits beyond lung imaging and boost health deep-tech on point-of-care imaging and multi-parameter-based digital health in the EU

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2022-PATHFINDEROPEN-01

See all projects funded under this call

Coordinator

UNIVERSITE PARIS-SACLAY
Net EU contribution
€ 1 243 413,75
Address
BATIMENT BREGUET - 3 RUE JOLIOT CURIE
91190 Gif-Sur-Yvette
France
Region
Ile-de-France Ile-de-France Essonne
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 487 157,50

Participants (14)

Partners (1)